GNH USA

Europe — EMA

Montelukast Accord Healthcare (Montelukast Sodium)

GNH USA supplies Montelukast Accord Healthcare (Montelukast), a leukotriene receptor antagonist for asthma maintenance, allergic rhinitis

Montelukast Sodium

Request sourcing

1
Pack/s

What is Montelukast Sodium?

Montelukast sodium, the active ingredient in Montelukast Accord Healthcare, is a leukotriene receptor antagonist presented as an oral tablet for oral use. It is indicated for maintenance therapy of asthma, relief of allergic rhinitis symptoms, and prevention of exercise‑induced bronchoconstriction in appropriate patients.

GNH USA supplies Montelukast Accord Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Montelukast Sodium used for?

Montelukast Accord Healthcare acts on the leukotriene pathway to manage respiratory and allergic conditions.

Asthma: reduces the frequency of bronchospasm and improves overall control. Allergic rhinitis: alleviates nasal congestion, sneezing and itching. Exercise‑induced bronchoconstriction: prevents airway narrowing during physical activity.

What are the side effects of Montelukast Sodium?

Montelukast is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache - Abdominal pain - Cough - Nausea

Serious or Rare Side Effects: - Angioedema - Stevens‑Johnson syndrome - Hepatic injury

What precautions apply to Montelukast Sodium?

Montelukast should be used with attention to specific safety considerations.

Pregnancy: safety not established; use only if clearly needed. Breastfeeding: unknown excretion; weigh benefits against potential risks. Drug‑inducing enzymes: concurrent phenobarbital or rifampin may lower effectiveness. Hepatic impairment: monitor liver function when indicated. Discontinuation: do not stop abruptly without medical guidance. Store below 25°C: keep in the original pack, protect from moisture.

What does Montelukast Sodium interact with?

Montelukast may interact with several medicines; monitoring is advised.

Major Interactions (Avoid): - Phenobarbital: enzyme induction reduces montelukast levels. - Rifampin: similar induction effect, decreasing efficacy. - Ketoconazole: may increase montelukast plasma concentrations.

Moderate Interactions (Monitor Closely): - Warfarin: potential alteration of anticoagulant effect. - Beta‑agonists: additive bronchodilation may require dose adjustment.

Frequently asked questions

What is Montelukast Accord Healthcare used for?+
Montelukast Accord Healthcare is prescribed for the long‑term maintenance treatment of asthma, for relief of symptoms associated with allergic rhinitis, and to prevent bronchoconstriction triggered by exercise in patients with documented exercise‑induced bronchospasm.
How does Montelukast work?+
Montelukast blocks the cysteinyl leukotriene receptor CysLT1, preventing leukotriene D4 from binding. This inhibition reduces airway narrowing, mucus production, and inflammation that are mediated by leukotrienes, thereby improving breathing and reducing allergic symptoms.
What is the usual dose of Montelukast Accord Healthcare?+
The appropriate dose is determined by the prescribing clinician based on the patient’s age, condition, and response to therapy. Montelukast is typically taken once daily in the evening, but exact dosing should follow the prescriber’s instructions.
Is Montelukast safe during pregnancy or breastfeeding?+
Safety data for Montelukast in pregnancy are limited, and the product is classified as having an unknown pregnancy category. It should be used only if the potential benefit justifies the potential risk. Likewise, it is excreted in breast milk, so breastfeeding mothers should discuss risks and benefits with their healthcare provider.
How do I order Montelukast Accord Healthcare from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and assistance with import documentation.
How does Montelukast compare with inhaled corticosteroids?+
Montelukast and inhaled corticosteroids (ICS) target different aspects of asthma control. Montelukast blocks leukotriene‑mediated inflammation, while ICS reduce a broader range of inflammatory pathways. Montelukast is often used as an add‑on therapy for patients who remain symptomatic on low‑dose ICS or who have specific allergic components, but it is not a substitute for high‑dose ICS in severe asthma.
How should Montelukast Accord Healthcare be stored and handled?+
The tablets should be stored at temperatures below 25 °C, in their original container, protected from moisture and direct sunlight. Keep out of reach of children and do not use if the packaging is damaged.
How is Montelukast administered?+
Montelukast Accord Healthcare is taken orally, usually as a whole tablet swallowed with water. It is commonly prescribed for once‑daily dosing in the evening, but patients should follow the specific timing advised by their prescriber.
What are the most serious risks associated with Montelukast?+
Serious adverse reactions, although rare, include angioedema, severe skin reactions such as Stevens‑Johnson syndrome, and hepatic injury. Patients should seek immediate medical attention if they experience swelling of the face or throat, rash with blistering, or signs of liver dysfunction such as jaundice.
Who should not use Montelukast Accord Healthcare?+
Montelukast is contraindicated in individuals with a known hypersensitivity to montelukast sodium or any of the tablet’s excipients. Caution is also advised for patients with severe hepatic impairment, and it should be avoided in those who have experienced serious allergic reactions to leukotriene‑modifying agents.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Montelukast Sodium
Route
Oral Use
Manufacturer
Accord Healthcare Limited
Origin
EU

Related products

Montelukast Sodium 10 mg/1

Montelukast Sodium 10 mg/1

Montelukast Sodium · 10 mg

Montelukast Sodium
TABLET, FILM COATED
Major Pharmaceuticals
USA
Montelukast Sodium 10 mg/1

Montelukast Sodium 10 mg/1

Montelukast Sodium · 10 mg

Montelukast Sodium
TABLET, FILM COATED
Major Pharmaceuticals
USA
Montelukast Sodium 4 mg/1

Montelukast Sodium 4 mg/1

Montelukast Sodium · 4 mg

Montelukast Sodium
TABLET, CHEWABLE
Torrent Pharmaceuticals Limited
USA
Montelukast Sodium 4 mg/1

Montelukast Sodium 4 mg/1

Montelukast Sodium · 4 mg

Montelukast Sodium
TABLET, CHEWABLE
Torrent Pharmaceuticals Limited
USA